Robert P Schleimer1, Ronald L Schnaar, Bruce S Bochner. 1. aDivision of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois bDepartment of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Inflammatory cells involved in the allergic response, including eosinophils, mast cells, basophils, and neutrophils, express sialoglycan-binding proteins such as Siglec-8 and Siglec-9, which inhibit cell function and survival. The purpose of this review is to briefly discuss the biology of these siglecs and their ligands and consider their potential impact in pathology and treatment of chronic rhinosinusitis (CRS). RECENT FINDINGS: Recent studies demonstrate the presence of ligands for Siglec-8 and Siglec-9 in sinonasal tissue from patients with CRS as well as healthy patients, suggesting that the immunoregulatory functions of siglecs may be triggered in sinus tissue in health and disease. SUMMARY: Ligands for Siglec-8 and Siglec-9 may regulate the function of eosinophils, mast cells, neutrophils, and other cells in sinus mucosa. Therapeutic strategies that activate the anti-inflammatory effects of siglecs may dampen inflammation and disease in CRS patients.
PURPOSE OF REVIEW: Inflammatory cells involved in the allergic response, including eosinophils, mast cells, basophils, and neutrophils, express sialoglycan-binding proteins such as Siglec-8 and Siglec-9, which inhibit cell function and survival. The purpose of this review is to briefly discuss the biology of these siglecs and their ligands and consider their potential impact in pathology and treatment of chronic rhinosinusitis (CRS). RECENT FINDINGS: Recent studies demonstrate the presence of ligands for Siglec-8 and Siglec-9 in sinonasal tissue from patients with CRS as well as healthy patients, suggesting that the immunoregulatory functions of siglecs may be triggered in sinus tissue in health and disease. SUMMARY: Ligands for Siglec-8 and Siglec-9 may regulate the function of eosinophils, mast cells, neutrophils, and other cells in sinus mucosa. Therapeutic strategies that activate the anti-inflammatory effects of siglecs may dampen inflammation and disease in CRSpatients.
Authors: Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy Journal: Am J Respir Crit Care Med Date: 2009-05-29 Impact factor: 21.405
Authors: P R Crocker; E A Clark; M Filbin; S Gordon; Y Jones; J H Kehrl; S Kelm; N Le Douarin; L Powell; J Roder; R L Schnaar; D C Sgroi; K Stamenkovic; R Schauer; M Schachner; T K van den Berg; P A van der Merwe; S M Watt; A Varki Journal: Glycobiology Date: 1998-02 Impact factor: 4.313
Authors: Caroline R Boyd; Selinda J Orr; Shaun Spence; James F Burrows; Joanne Elliott; Helen P Carroll; Kiva Brennan; Joan Ní Gabhann; Wilson A Coulter; Claire Jones; Paul R Crocker; James A Johnston; Caroline A Jefferies Journal: J Immunol Date: 2009-12-15 Impact factor: 5.422
Authors: Dae Jin Song; Jae Youn Cho; Sang Yeub Lee; Marina Miller; Peter Rosenthal; Pejman Soroosh; Michael Croft; Mai Zhang; Ajit Varki; David H Broide Journal: J Immunol Date: 2009-09-25 Impact factor: 5.422
Authors: Markus O Henke; Armin Renner; Rudolf M Huber; Michael C Seeds; Bruce K Rubin Journal: Am J Respir Cell Mol Biol Date: 2004-02-26 Impact factor: 6.914
Authors: Huifeng Yu; Anabel Gonzalez-Gil; Yadong Wei; Steve M Fernandes; Ryan N Porell; Katarina Vajn; James C Paulson; Corwin M Nycholat; Ronald L Schnaar Journal: Glycobiology Date: 2017-07-01 Impact factor: 4.313
Authors: Anabel Gonzalez-Gil; Ryan N Porell; Steve M Fernandes; Yadong Wei; Huifeng Yu; Daniela J Carroll; Ryan McBride; James C Paulson; Michael Tiemeyer; Kazuhiro Aoki; Bruce S Bochner; Ronald L Schnaar Journal: Glycobiology Date: 2018-10-01 Impact factor: 4.313